Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-24 @ 11:30 PM
NCT ID:
NCT01648556
Eligibility Criteria:
Inclusion Criteria:
* Rate of platelet \< 100 G/l for less than 12 months ,
* age = ou \> 60 years,
* haemoglobin \> ou = 12 g / dl at the woman, \> ou = 13 g/dl at the man,
* polymorphonuclear neutrophil \> ou = 1.7 G/l,
* monocytes \< ou= 1 G/l,
* lymphocytes \< ou = à 4 G/l,
* VGM \< 100 fL, blood film normal,
* informed consent,
* expectation of life \> 6 months
Exclusion Criteria:
* hepatomegaly,
* splenomegaly,
* hepatic abnormality,
* blood coagulation abnormality,
* antecedent of auto-immune disease,
* drug thrombopenia,
* HIV, VHB or VHC positive,
* antecedent of malicious tumor in the 5 years before inclusion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT01648556
Study Brief:
Protocol Section:
NCT01648556